NCT00481845 2017-02-07Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast CancerStanford UniversityPhase 2 Terminated1 enrolled 8 charts